Published on Journal of Alzheimer's Disease (https://www.j-alz.com)

Home > An Exploratory Phase IIa Study of the PPAR delta/gamma Agonist T3D-959 Assessing Metabolic and Cognitive Function in Subjects with Mild to Moderate Alzheimer’s Disease

An Exploratory Phase IIa Study of the PPAR delta/gamma Agonist T3D-959 Assessing Metabolic and Cognitive Function in Subjects with Mild to Moderate Alzheimer’s Disease

Manuscript Number: 

19-0864R1

Author(s): 
Stan Chamberlain, John Didsbury, Hoda Gabriel, Warren J. Strittmatter
Source URL: https://www.j-alz.com/manuscript-disclosures/19-0864r1